Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Phenylalkanoic acid derivatives as alpha4 integrin inhibitors; use in immune, inflammatory disorders

May 22, 2000

Synthesis and biological activity of new cell adhesion inhibitors described by Nihon Nohyaku

May 22, 2000

New oral antisense inhibitor of TNF-alpha emerges from Isis/Elan collaboration

May 22, 2000

Ciblex's CBX-10913 blocks inflammation in mice

May 19, 2000

Structure of COX-2 reaction revealed; COX-2-selective compound developed

May 18, 2000

Kyowa Hakko discloses new MAbs for treating or diagnosing inflammatory, autoimmune disorders

May 12, 2000

Multitarget antiinflammatory agents designed at Merckle

May 11, 2000

New compounds from AstraZeneca for cytokine-mediated conditions

May 10, 2000

Synthesis, activity and therapeutic use of new LTA4 hydrolase inhibitors

May 8, 2000

Effects of COX-2 inhibition on blood pressure and leukocyte adherence explored

May 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...